Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch.
Weidemann F, Krämer J, Duning T, Lenders M, Canaan-Kühl S, Krebs A, Guerrero González H, Sommer C, Üçeyler N, Niemann M, Störk S, Schelleckes M, Reiermann S, Stypmann J, Brand SM, Wanner C, Brand E.
Weidemann F, et al. Among authors: brand sm, brand e.
J Am Soc Nephrol. 2014 Apr;25(4):837-49. doi: 10.1681/ASN.2013060585. Epub 2014 Feb 20.
J Am Soc Nephrol. 2014.
PMID: 24556354
Free PMC article.